Immune Thrombocytopenia research hub

A Phase 1, Randomized, Double-Blind, Two-Arm, Two-Way Crossover Study of Pharmacokinetics and Pharmacodynamics of QL0911

This study is looking at a new medicine, QL0911, for two conditions: Immune Thrombocytopenia (low platelets) and Acute Radiation Syndrome (a serious illness from radiation exposure). It's an early-stage study to understand how the medicine works in the body.